Filter
1239
Text search:
TB
financing
Featured
76
422
Language
Document type
859
178
62
61
36
24
6
5
4
3
1
Countries / Regions
66
45
40
39
35
34
33
32
32
32
31
31
29
27
26
24
24
23
21
21
19
18
18
16
15
14
11
11
11
10
10
9
7
7
7
6
6
6
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
635
57
32
24
20
7
4
1
Toolboxes
221
164
41
40
35
28
18
18
17
16
10
10
10
9
9
9
8
8
6
2
1
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of
...
Accessed: 19.10.2019
Copenhagen, Denmark, 7–8 March 2017. Meeting report
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access
...
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the
...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country
...
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though
...
This strategic framework marries formerly separate mandates for HIV and TB management in to one, comprehensive collaboration. It provides a structure for how to: strengthen the health care system to respond effectively to both epidemics, reduce the
...
